Business Description
MedinCell is a French biopharmaceutical company founded in 2003 and headquartered in Jacou, France. The company specializes in long-acting injectable medicines built on its proprietary BEPO technology, which allows drugs to be released slowly in the body over extended periods. Its lead commercial product, UZEDY, is already approved for treating schizophrenia and bipolar I disorder in adults, while several other treatments for conditions such as postoperative pain, malaria, and contraception are at various stages of development. MedinCell works alongside partners including AbbVie and IM4TB to bring additional long-acting injectable therapies to market across a range of medical fields.
